This is our most recent Estrogens Properties Table by Beverly Cosgrove and Juno Krahn — [Version 14, Nov 28, 2017]. The chart is intended to present estrogens as used as either suppressing testosterone (without using antiandrogens) or for the purpose of post-op maintenance. Some data is from “Cardiovascular Disease in transsexual persons…” Gooren LJ, Eur J Endo, 2014 Jun:170(6):809-19 and “Pharmacology of Estrogens and Progestogens — Influence of Different Methods of Administration” by Kuhl, from Climacteric, 2005;8 Suppl 1:3-63. The table may also represent unpublished research and non-medical opinions of the authors. Some risk data is extrapolated or inferred. This is for educational purposes only, not for medical use. DOSAGE INFORMATION is only representative of a typical dose. Doses can vary by a factor of 2-3, depending on the individual. Dose information here is to be regarded as unreliable unless verified by each patient with blood tests. Some terms: DVT: Deep Vein Thrombosis, a blood clot originating in the veins mostly due to fibrinolysis and can cause pulmonary embolism; “Clot”: platelet-based clotting which can lead to heart attack and other dangers; “Lipids”: undesirable blood lipoprotein effects; “CRP”: C-Reactive Protein, one of many inflammatory markers associated with cardiovascular problems; “SHBG”: Sex Hormone Binding Globulin, an indicator of the effort being made by the liver to detoxify sex hormones in the blood stream or the portal vein system.